A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2001
12/06/2001	CA2410660A1 Cyclohexylamine derivatives as subtype selective nmda receptor antagonists
12/06/2001	CA2410597A1 Melanocortin receptor agonists
12/06/2001	CA2410084A1 Transporters and ion channels
12/06/2001	CA2409927A1 Combinations of an endothelin receptor antagonist and an antiepileptic compound having pain alleviating properties or analgesic
12/06/2001	CA2409617A1 2,7-naphthyridine derivatives
12/06/2001	CA2409597A1 Protein kinase inhibitors
12/06/2001	CA2409311A1 Regulators of apoptosis
12/06/2001	CA2409006A1 Biciclic cyclohexylamines and their use as nmda receptor antogonists
12/06/2001	CA2406979A1 Indole derivatives with vascular damaging activity
12/06/2001	CA2380367A1 Compositions for providing zinc through oral administration
12/05/2001	EP1160254A1 Human vanilloid receptor-like proteins
12/05/2001	EP1160240A1 Guanylhydrazones for treating inflammatory conditions
12/05/2001	EP1159970A2 A pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss, comprising a nicotine receptor partial agonist and an anti-obesity agent
12/05/2001	EP1159457A1 T cell receptor vbeta beta-jbeta) sequence and methods for its detection
12/05/2001	EP1159418A2 Muc-1 antagonists and methods of treating immune disorders
12/05/2001	EP1159412A2 Composition, methods and reagents for the synthesis of a soluble form of human phex
12/05/2001	EP1159300A2 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
12/05/2001	EP1159292A2 Compounds having growth hormone releasing activity
12/05/2001	EP1159286A1 Tumor necrosis factor receptors 6 alpha and 6 beta
12/05/2001	EP1159284A1 33 human secreted proteins
12/05/2001	EP1159262A1 Tyrosine alkoxyguanidines as integrin inhibitors
12/05/2001	EP1159006A2 Water-soluble compositions of bioactive lipophilic compounds
12/05/2001	EP1159004A1 Novel redox clamping agents and uses thereof
12/05/2001	EP1158996A1 Novel amide derivatives as growth hormone secretagogues
12/05/2001	EP1158986A1 Protease inhibitors
12/05/2001	EP1158872A1 Dietary compositions and methods
12/05/2001	EP1146050A9 Remedies
12/05/2001	EP0994872B9 4-phenylpiperidine compounds
12/05/2001	EP0971880B1 Solid compositions suitable for oral administration comprising non hygroscopic salts of l-carnitine and alkanoyl-l-carnitine with 2-aminoethanesulfonic acid
12/05/2001	EP0835263B1 Somatostatin peptides
12/05/2001	EP0814815A4 Poly(hydroxy acid)/polymer conjugates for skin applications
12/05/2001	EP0720484B1 Plant material for controlling immune responses in mammals and method for producing the material
12/05/2001	CN1325408A Compounds with growth hormone releasing propenties
12/05/2001	CN1325407A Platelet-derived growth factor D, DNA coding therefor and uses thereof
12/05/2001	CN1325399A Pyrroloindoles, pyridoindoles and azepinoindoles as 5-HT2c agonists
12/05/2001	CN1325384A Anthranilic acid amides and the use thereof as medicaments
12/05/2001	CN1325310A Remedies for bone metabolic errors
12/05/2001	CN1325302A Use of dialkylfumarates
12/05/2001	CN1325299A Orally administered controlled drug delivery system providing temporal and spatial control
12/05/2001	CN1324951A High-efficiency expression and application of human recombinant interferon B
12/05/2001	CN1324864A Trivalent chromium compound and its milk product and making process
12/05/2001	CN1324653A Health food capable of regulating blood lipoid and delaying senility
12/05/2001	CN1324627A Diabetes treating medicine and its prepn. method
12/05/2001	CN1324619A Health capsule of pure active chitosan and animal fiber
12/05/2001	CN1324618A Pharmaceutical use of benzoic acid derivatives
12/05/2001	CN1324580A Health food containing active nutritious protein and its production process
12/05/2001	CN1075816C Methods for in vivo reduction of nitric oxide levels and compositions sueful therefor
12/05/2001	CN1075812C Prodrugs of morpholine tachykinin receptor antagonists
12/05/2001	CN1075811C Substituted 2,4-thiazolindione derivative, its preparation method and medicinal composition containing same
12/05/2001	CN1075809C Novel vitamin D analogues
12/05/2001	CN1075735C Compound diabetes-treating Chinese medicine preparation and its preparing method thereof
12/05/2001	CN1075729C Hypoglycemic paste
12/04/2001	US6326475 Dry acid-chitosan complexes
12/04/2001	US6326398 Oxamic acids and derivatives as thyroid receptor ligands
12/04/2001	US6326385 Administering poltassium channel modulator
12/04/2001	US6326378 Use of thiadiazolo[4,3-a]pyridine derivatives
12/04/2001	US6326367 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
12/04/2001	US6326359 Adenosine A2A receptor agonists as antiinflammatory agents
12/04/2001	US6326355 Method for the prevention and treatment of cachexia and anorexia
12/04/2001	US6326201 Isolating stem cells of pancreas; obtain pancreatic tissue, dissociate and obtain pancreatic duct tissue, culture, isolate stem cells cells
12/04/2001	US6326141 Detecting pancreatic defect; evaluate humans for preferential gene expression, compare to healty human, amplified expression from preferential gene indicates pancreatic defect
12/04/2001	US6325999 Use of Fas ligand to suppress T-lymphocyte-mediated immune responses
12/04/2001	CA2218452C Novel ligands of the neuropeptide receptor hfgan72
12/04/2001	CA2208836C Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
12/04/2001	CA2124763C Lipase inhibitor derived from a defatted rice germ
12/04/2001	CA2000553C Process for the preparation of 7-substituted-hept-6-enoic and -heptanoic acids and derivatives and intermediates thereof
12/02/2001	CA2349388A1 A pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss
11/2001
11/29/2001	WO2001090371A1 Mutated eukariotic translation initiation factor 2 alpha kinase 3, eif2ak3, in patients with neonatal insulin-dependent diabetes and multiple epiphyseal dysplasia (wolcott-rallison syndrome)
11/29/2001	WO2001090359A2 G-protein coupled receptors
11/29/2001	WO2001090341A1 Antisense modulation of pten expression
11/29/2001	WO2001090334A2 Drug metabolizing enzymes
11/29/2001	WO2001090189A2 G-protein coupled receptor org3.
11/29/2001	WO2001090155A2 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
11/29/2001	WO2001090148A2 Neurotransmitter transporters
11/29/2001	WO2001090110A1 Macrolides
11/29/2001	WO2001090106A2 Tryasolyl tropane derivatives as ccr5 modulators
11/29/2001	WO2001090104A2 -(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases
11/29/2001	WO2001090103A2 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators
11/29/2001	WO2001090094A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001	WO2001090093A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001	WO2001090092A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001	WO2001090091A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001	WO2001090090A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001	WO2001090086A1 A polymorph of 5-(4-aminosulfonyl-3-fluorophenyl)-4-cyclohexyl-2-methyloxazole
11/29/2001	WO2001090081A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
11/29/2001	WO2001090070A2 Caspase inhibitors and uses thereof
11/29/2001	WO2001090068A2 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use a modulators of protein kinases
11/29/2001	WO2001090067A1 Tyrosine phosphatase inhibitors
11/29/2001	WO2001090063A2 Prodrug of an ice inhibitor
11/29/2001	WO2001090061A1 5,6-trans-2-alkylvitamin d derivatives
11/29/2001	WO2001090060A1 Disulfide derivatives useful for treating allergic diseases
11/29/2001	WO2001089570A2 Combination of growth hormone secretagogues and antidepressants
11/29/2001	WO2001089569A1 Combinations of enzyme inhibitor-containing preparations and the use thereof
11/29/2001	WO2001089557A2 Methods for preventing strokes by inducing tolerance to e-selectin
11/29/2001	WO2001089551A1 Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes
11/29/2001	WO2001089550A2 Use of ciliary neurotrophic factor
11/29/2001	WO2001089536A2 Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
11/29/2001	WO2001089532A1 Preparation of fagopyritols and uses therefor
11/29/2001	WO2001089523A1 New pharmaceutical composition and the process for its preparation
11/29/2001	WO2001089520A2 Dehydroascorbic acid formulations and uses thereof

1 ... 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 ... 1298